Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Monirul I. Sajib"'
Publikováno v:
Antibiotics, Vol 12, Iss 5, p 936 (2023)
Cefiderocol is a novel cephalosporin recently approved by the FDA to aid clinicians in the fight against multidrug-resistant (including carbapenem-resistant) gram-negative organisms. The primary objective of this study is to evaluate the 14- and 28-d
Externí odkaz:
https://doaj.org/article/706df2d6ad8d44afab86d42d13b078b2
Publikováno v:
Pathogens, Vol 12, Iss 3, p 503 (2023)
Cases of rocky mountain spotted fever (RMSF) are increasingly reported every year in Long Island, New York. In clinical practice, an uncommonly high number of referrals with a positive RMSF IgG test result have been seen in our tick-borne disease cli
Externí odkaz:
https://doaj.org/article/e1bba11a44504c089bb0f72f19243db7
Publikováno v:
Infectious Diseases in Clinical Practice. 31
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35ddc3dbb1f4717c50f626491850c39b
https://doi.org/10.1097/ipc.0000000000001224
https://doi.org/10.1097/ipc.0000000000001224
Publikováno v:
Open Forum Infectious Diseases. 9
Background Cefiderocol has emerged recently as a new tool for combating multidrug-resistant bacterial infections; however, concerns about its efficacy has approved its FDA approval for the use in person with limited or no treatment options. The aim o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b28d9a3a5e4598cccaa3c9b740e8136e
https://doi.org/10.1093/ofid/ofac492.692
https://doi.org/10.1093/ofid/ofac492.692
Publikováno v:
Open Forum Infectious Diseases. 9
Background Multidrug-resistant organisms (MDRO) in long-term care facilities are prevalent and pose a major health concern for their residents. During the COVID-19 pandemic, infection control measures were justifiably heightened in every aspect of he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b38c2c7d5379551f2d4b72793091f94
https://doi.org/10.1093/ofid/ofac492.1055
https://doi.org/10.1093/ofid/ofac492.1055
Publikováno v:
Open Forum Infectious Diseases. 2023 Supplement, Vol. 10, pS1-S1274. 3913p.
Publikováno v:
Open Forum Infectious Diseases. 2022 Supplement, Vol. 9, pS1-S936. 2220p.
Publikováno v:
Antibiotics (2079-6382); May2023, Vol. 12 Issue 5, p936, 9p
False-Positive Serology for Rocky Mountain Spotted Fever in Long Island, New York, during 2011–2021.
Publikováno v:
Pathogens; Mar2023, Vol. 12 Issue 3, p503, 7p
Publikováno v:
Infectious Diseases in Clinical Practice; Mar2023, Vol. 31 Issue 2, p1-2, 2p